Selling Your Veterinary Practice to EverVet Partners: A Vet’s 2026 Guide

Key takeaways

• EverVet Partners is a private equity-backed veterinary acquisition and support platform founded in 2020 by Joe Luceri and Len Podolsky, headquartered in Conshohocken, Pennsylvania.
• EverVet is co-owned by two private equity firms — Freeman Spogli & Co. and Tailwind Capital — as equal partners, with founders and management retaining shareholding and operating control, per Freeman Spogli’s own announcement.
• The through-line is a doctor-partnership model: EverVet describes partnering with hospitals rather than dictating to them, keeping each practice independently branded and operated and preserving its history and values, per EverVet’s materials.
• Sellers get a choice of structure — a 100% sale or a joint-venture (JV) partnership where the owner keeps equity and “takes some chips off the table,” with the structure tailored case by case.
• The most reliable way to learn what EverVet — or any buyer — would actually pay for your specific practice is a structured competitive process. We call ours the Elite Selling System: we hand-select and vet every buyer who gets to bid, the way a doorman with a velvet rope lets in only the right people, then run a private bidding window inside that vetted group. EverVet is welcome inside that rope on practices that fit its model — and a curated group of qualified bidders reliably surfaces a different number than a single direct conversation.

When a vet hands me an EverVet Partners offer, the conversation almost always starts in the same place. The owner likes how EverVet talks.

The language is warm — partnership, autonomy, keeping your name on the door, working with hospitals rather than dictating to them. And it isn’t empty language; it tracks closely with how EverVet actually describes itself.

So the first thing I do is reassure the owner that their read is fair. EverVet’s positioning is genuinely seller-friendly, and that’s part of why it lands.

Then I do the second thing, which is the part owners tend to skip. I separate the positioning from the paper.

Warm language about autonomy and partnership is the starting frame of a relationship. The numbers and the protective terms are the contract.

Both matter, and the gap between a good EverVet outcome and a mediocre one lives almost entirely in how that contract gets shaped.

What follows is the picture I’d lay out over dinner if you handed me an EverVet term sheet and asked what to do with it. Who owns EverVet, how big the network is, what its doctor-partnership model actually means for you, the real difference between a 100% sale and a joint venture, how it values a practice, and where your leverage sits when you sit down to negotiate.

Who owns EverVet Partners? (Freeman Spogli & Co. and Tailwind Capital)

EverVet Partners is co-owned by two private equity firms — Freeman Spogli & Co. and Tailwind Capital — as equal partners, with EverVet’s founders and management retaining shareholding and operating control. Tailwind was the original sponsor.

Freeman Spogli made a significant investment in August 2022, announced August 16, 2022, and became an equal partner. Per Freeman Spogli’s own release, the founders and management remained shareholders and continued running day-to-day operations.

That structure is worth slowing down on, because it shapes how a sale to EverVet feels. EverVet is PE-backed — private equity provides the capital that funds acquisitions.

But the founders, Joe Luceri and Len Podolsky, stayed in the chairs and kept operating control through the Freeman Spogli investment. So a seller is dealing with a founder-led operating team funded by institutional capital, not a pure financial buyer with no operators in the room.

A quick word on the sponsor itself. Freeman Spogli is a consumer- and distribution-focused private equity firm founded in 1983 that, per its own materials, has invested over $5.5 billion across 69 platform companies.

When it backed EverVet, it framed the platform as a “preferred partner to veterinarian business owners” in an attractive veterinary services market. The point for a seller is simple.

EverVet sits on real institutional capital, which means the platform has the financial capacity to compete for practices that fit its model.

EverVet’s footprint: how many hospitals and which regions

EverVet operated 21 animal hospital clinics across 10 states at the time of the August 2022 Freeman Spogli investment, per Freeman Spogli’s announcement. That’s the most reliable hard number, because it comes straight from the press release tied to a specific date.

More recent figures get a little softer, so I’ll flag the hedge. A 2025-2026 third-party industry roundup (Vet Integrations) puts the current network at approximately 25 hospitals across 8 states, with acquisitions concentrated in the Mid-Atlantic, Midwest, Northeast, and Southeast.

EverVet’s own site shows an interactive hospital map but does not state a current total numerically, so treat the ~25 figure as approximate and current-as-of that roundup rather than an official EverVet count.

For a seller, the practical read is this. EverVet is a focused, regional platform, not a national giant blanketing every market.

That regional concentration matters when you’re evaluating fit, because platforms tend to bid most seriously where they’re building density — referral relationships, shared back-office, and recruiting are all easier inside an existing cluster. If your practice sits in or near EverVet’s core regions, you’re squarely in their lane.

EverVet’s model: independently branded, doctor-partnership approach

EverVet’s distinctive through-line is a partnership posture: “we partner with hospitals rather than dictate to hospitals.”

Per EverVet’s own materials, that model keeps acquired practices independently branded and operated, preserving each practice’s history and values with a customized, bespoke approach. EverVet also speaks directly to seller autonomy: “You know your practice, patients, and staff best.

We work with you to ensure your voice shapes our approach, offering the autonomy you prefer.” It states its core values as Teamwork, Transparency, Empathy, and Integrity, and describes partnerships as “natural, transparent, seamless, and mutually rewarding.”

On the operations side, EverVet says it provides post-sale support — resources, peer communities, ownership options, and growth strategies — so owners can focus on medicine rather than business management. In October 2025, EverVet partnered with CoVet to roll out an AI “copilot” across its hospital network for clinical documentation, medical-history review, client communication, and administrative automation.

That’s a concrete example of the kind of operational support a smaller independent practice usually can’t build on its own.

Here’s how I’d frame all of that for a seller. The independently-branded approach is real and is one of EverVet’s genuine selling points — it sits closer to the brand-preservation end of the buyer spectrum than to the aggressive-rebrand end.

The thing to remember is that company materials describing a “general approach” are not the same as a contractual commitment in your purchase agreement. The philosophy is the reason to like EverVet.

The contract language is what actually binds it. We’ll come back to that in the negotiation section.

Selling to EverVet: 100% sale vs. joint-venture (rollover equity) options

This is the dimension that most distinguishes an EverVet conversation, and it’s a genuinely good thing for sellers: EverVet gives you a choice of structure.

Per EverVet’s Practice Sales 101 materials, a selling owner can choose between a 100% sale and a joint venture (JV) partnership — a sale structure where the buyer takes a majority stake and the owner keeps a minority equity stake, “taking some chips off the table” while staying invested in the upside. EverVet describes these partnership structures as tailored rather than one-size-fits-all.

On its Partner with Us page, it offers either continued ownership or a full exit.

The plain-English version. If you want a clean break — sell the whole thing, wind down your involvement, move on — the 100% sale path exists.

If you’d rather de-risk by cashing out the majority of your practice’s value now but keep a slice of ownership (rollover equity, meaning you keep a portion of the upside instead of taking all cash at close), the JV path exists. The retained stake gives you a shot at a second liquidity event if the platform grows and is eventually sold again.

Neither structure is automatically better. A clean exit is simpler and removes your exposure to the platform’s future.

A JV keeps you exposed — which is upside if the platform does well and risk if it doesn’t. The retained-equity decision is one of the highest-stakes calls in the whole transaction, and it deserves to be modeled out, not decided on instinct.

Our PE pricing guide walks through the structure-by-structure comparison in depth, and our overview of how to sell a veterinary practice covers where this decision fits in the broader timeline.

How EverVet values a veterinary practice (and what drives the multiple)

EverVet does not publish a price sheet, and you wouldn’t want it to — a fixed sheet ignores everything specific about your practice. What EverVet does tell sellers, in its Practice Sales 101 materials, is what goes into the valuation.

EverVet says its valuation considers location, financial performance (consistent profits and a healthy balance sheet), facility size and layout, equipment and technology, and staff expertise. It also makes a point that matters more than owners expect: the relationship with key staff is “of the utmost importance,” whether the deal is a JV or a 100% sale. That’s a signal worth reading.

A buyer that cares about staff retention is telling you it values continuity, and continuity is part of what it’s paying for.

The piece EverVet’s materials can’t tell you — and no buyer’s materials ever can — is what your specific practice will clear. Practice price comes down to EBITDA (what your practice earns in pure operating profit, before taxes and accounting choices) multiplied by a multiple (the multiplier buyers apply to set the price).

The single biggest variable in that multiple isn’t on EverVet’s valuation checklist at all. It’s whether other qualified buyers are competing for your practice at the same time.

Our deeper guide on how to value a veterinary practice breaks down how EBITDA gets normalized and what moves the multiple.

Have an offer from EverVet Partners? Get a Free Practice Value Estimate — send us the offer and we’ll decompose the terms, identify what’s typically negotiable, and project what your practice would likely clear in a structured competitive process with the broader qualified buyer pool. No upfront cost, no obligation.

Leadership and track record (founders, CEO transition, recent deals)

EverVet was founded in 2020 by Joe Luceri and Len Podolsky — a recently built platform rather than a decades-old one, which is part of why the founder-operator presence is still so central to how it runs.

In February 2024, co-founder and COO Len Podolsky was named CEO, while co-founder and former CEO Joe Luceri became Chairman of the Board, per EverVet’s leadership announcement. The current leadership team, per EverVet’s About page, includes Len Podolsky (Co-Founder & CEO), Sean Sornsin (COO), Kyle Bailey (CFO), and Lindsay Kennedy (SVP of Growth). That’s a meaningful detail for a seller: a CEO transition that kept both founders in leadership signals continuity at the top rather than a clean-out, which is consistent with the partnership story EverVet tells.

On deal activity, EverVet’s most recently disclosed acquisition was Landrum Veterinary Hospital, with a transaction date of February 9, 2025, per PitchBook’s third-party database — I’ll flag that the date is from a data provider, not an EverVet press release, so treat it as reported rather than independently confirmed. The broader signal is that EverVet is an active, currently acquiring platform with a founder-led team and institutional capital behind it.

How EverVet compares to the other major buyers

If you’re weighing EverVet, you’re implicitly weighing it against the rest of the qualified field. A few honest, neutral contrasts.

Versus Mars Veterinary Health (VCA, BluePearl, Banfield). Mars is the strategic, family-owned exception in the buyer pool — not PE-backed. EverVet’s independently-branded approach sits at a different point on the spectrum than VCA’s historical brand-consolidation pattern.

Both can compete for qualifying practices in a structured process.

Versus NVA (JAB Holdings). NVA, owned by JAB Holdings, is a large platform that, like EverVet, preserves local practice branding per their respective materials. The main contrasts are scale and ownership horizon — EverVet is a smaller, regionally focused, PE-fund-backed platform.

Our NVA buyer profile covers the NVA-specific dimensions.

Versus the broader PE-backed pool. EverVet’s structural-choice flexibility (100% sale or JV) is a feature it shares with several other PE-backed buyers that emphasize partnership structures. The right way to compare them is not buyer by buyer in the abstract — it’s to put the genuinely competing ones in the same room on your specific practice.

Our overview of veterinary practice consolidators maps the full landscape, and who to sell your veterinary practice to walks through matching buyer type to seller goals.

Is EverVet the right buyer for your practice? How a sell-side advisor helps you compare

EverVet is a serious buyer with a genuinely seller-friendly model — founder-led, independently-branded, autonomy-preserving, with a real choice between a clean exit and a partnership. For the right practice in the right region, it can be an excellent home.

The question isn’t whether EverVet is a good buyer. It’s whether EverVet’s specific offer is the best available outcome for your specific practice — and you can’t answer that without seeing the rest of the field.

That’s the gap a structured process closes, and it’s the whole reason our work exists.

What our Elite Selling System actually does

The mechanics are straightforward and they’re the same for any buyer, EverVet included.

We hand-select and vet every buyer who gets to bid on your practice, the way a doorman with a velvet rope lets in only the right people — then we run a private bidding window inside that vetted group. EverVet is invited inside that rope on practices that fit its model.

The difference a competitive window makes is structural, not adversarial: a single buyer in a direct, one-on-one conversation has no reason to lead with its strongest cash percentage, tightest protective terms, or most flexible structure. When qualified buyers know others are underwriting the same practice in parallel, every term becomes negotiable.

That’s true of EverVet and it’s true of every other buyer in the pool.

We run a term-by-term comparison, not a headline-number comparison. Bidders return full term sheets — cash at close, the JV-versus-100%-sale structure, rollover equity terms, post-sale role and compensation, non-compete scope, staff and brand commitments. You choose on the dimensions that matter to you.

Sometimes that’s the highest number. Sometimes it’s the buyer whose model and people you trust most — which, for plenty of owners, is exactly why EverVet ends up at the front of the pack.

A few terms are worth your sharpest attention with any partnership-style buyer. If you’re considering EverVet’s JV path, model the rollover-equity terms carefully — the buyout window, the formula for valuing your retained stake later, and your information and minority-protection rights.

Get the brand-preservation and autonomy language that drew you to EverVet written explicitly into the definitive purchase agreement, not left as philosophy. And make sure the staff commitments EverVet emphasizes are reflected in the actual deal terms.

When you prepare a practice for sale with us, part of the work is a thorough pre-sale financial review on our side of the table — built around exactly the kind of scrutiny the buyers’ accountants will run, but before any buyer sees your numbers. That gives us months to clean up anything that wouldn’t survive a deep review.

The economic result holds across deal types. Practices in the qualifying revenue band that run our process consistently clear materially better total outcomes than the same practice would have cleared by signing the original direct term sheet without exploring the field.

Closing thought

The honest read on EverVet Partners: it’s a founder-led, PE-backed regional platform with a genuinely seller-friendly model — independent branding, real autonomy language, and a structural choice between a clean exit and a partnership with retained equity. Plenty of owners will like what they see, and they’ll be right to.

What separates a strong EverVet outcome from an average one isn’t whether you like the pitch. It’s whether the warm positioning makes it into the paper, and whether the number on the table is the best the market would actually pay.

Both of those get decided in the negotiation, and both move in your favor when EverVet is bidding alongside a curated group of qualified buyers instead of talking to you alone.

If you’ve received an EverVet offer, or their team has reached out to start the conversation, the highest-leverage move is to understand how the rest of the field would structure the same practice before you commit. Get a Free Practice Value Estimate and we’ll lay out the same term-by-term comparison we would for a client across a dinner table.

Frequently asked questions

Who owns EverVet Partners?

EverVet Partners is co-owned by two private equity firms — Freeman Spogli & Co. and Tailwind Capital — as equal partners, with EverVet’s founders and management retaining shareholding and operating control. Tailwind was the original sponsor; Freeman Spogli made a significant investment in August 2022 and became an equal partner, per Freeman Spogli’s own announcement.

Founders Joe Luceri and Len Podolsky continue to run day-to-day operations.

Is EverVet Partners private equity backed?

Yes. EverVet Partners is a private equity-backed veterinary platform.

It is co-owned by Freeman Spogli & Co. and Tailwind Capital as equal partners, with founders and management retaining shareholding and operating control. EverVet was founded in 2020 by Joe Luceri and Len Podolsky and is headquartered in Conshohocken, Pennsylvania, per EverVet’s own materials and Freeman Spogli’s press release.

How many veterinary hospitals does EverVet Partners own?

EverVet operated 21 animal hospital clinics across 10 states at the time of the August 2022 Freeman Spogli investment, per Freeman Spogli’s announcement. A 2025-2026 third-party industry roundup (Vet Integrations) puts the network at approximately 25 hospitals across 8 states, concentrated in the Mid-Atlantic, Midwest, Northeast, and Southeast.

EverVet does not state a current total numerically on its own site, so treat the figure as approximate.

What is the difference between a joint venture and a 100% sale with EverVet?

EverVet offers selling owners a choice. In a 100% sale, the owner sells the entire practice and can structure a full exit.

In a joint-venture (JV) partnership, the owner sells a majority stake and retains equity in the practice — “taking some chips off the table” while staying invested in the upside, per EverVet’s Practice Sales 101 materials. The right structure depends on whether you want a clean exit or continued ownership and a possible second liquidity event later.

Does EverVet Partners keep practices independently branded?

Yes, per EverVet’s own materials. EverVet describes a “we partner with hospitals rather than dictate to hospitals” model that keeps practices independently branded and operated, preserving each practice’s history and values with a customized approach.

EverVet also tells sellers they retain autonomy: “You know your practice, patients, and staff best,” and offers either continued ownership or a full exit.

How does EverVet Partners value a veterinary practice?

Per EverVet’s Practice Sales 101 materials, EverVet’s valuation considers location, financial performance (consistent profits and a healthy balance sheet), facility size and layout, equipment and technology, and staff expertise. EverVet says the relationship with key staff is “of the utmost importance” whether the deal is a JV or a 100% sale.

As with any buyer, the actual number depends heavily on whether other qualified buyers are competing for the practice.

Who is the CEO of EverVet Partners?

Len Podolsky is the Co-Founder and CEO of EverVet Partners. He was named CEO in February 2024, when co-founder and former CEO Joe Luceri became Chairman of the Board, per EverVet’s leadership announcement.

EverVet’s broader leadership includes Sean Sornsin (COO), Kyle Bailey (CFO), and Lindsay Kennedy (SVP of Growth).

Is EverVet Partners a good buyer for my veterinary practice?

EverVet is a serious, active buyer for practices that fit its regional, doctor-partnership model — independently branded, autonomy-preserving, with a choice between a 100% sale and a joint-venture partnership. Whether EverVet is the right buyer for your specific practice depends on your goals and how their offer compares to the rest of the qualified field.

The most reliable way to find out is to put EverVet in a structured competitive process alongside other vetted buyers.

Sources

EverVet Partners and parent company materials

1. EverVet Partners. “About EverVet Partners.” evervetpartners.com
2. EverVet Partners. “Partner with Us.” evervetpartners.com
3. EverVet Partners. “Practice Sales 101: How Valuations Are Calculated.” evervetpartners.com
4. EverVet Partners. “EverVet Partners Names Len Podolsky Chief Executive Officer.” evervetpartners.com
5. Freeman Spogli & Co. “EverVet Partners with Freeman Spogli & Co. to Accelerate Growth.” 2022. freemanspogli.com
6. PR Newswire. “EverVet Partners with Freeman Spogli & Co. to Accelerate Growth.” August 2022. prnewswire.com
7. CoVet. “CoVet and EverVet Partners Join Forces to Bring AI-Powered Efficiency to Veterinary Practices.” 2025. co.vet

Industry research and deal data

8. Vet Integrations. “Roll Call: North America’s Biggest Veterinary Consolidators.” vetintegrations.com
9. PitchBook. “EverVet Partners — Company Profile.” pitchbook.com